GOTTLIEB, A. B.; DEODHAR, A.; MCINNES, I. B.; BARALIAKOS, X.; REICH, K.; SCHREIBER, S.; BAO, W.; MARFO, K. .; RICHARDS, H. B.; PRICOP, L.; SHETE, A.; TRIVEDI, V.; KEEFE, D.; PAPAVASSILIS, C. C.; JAGIELLO, P.; PAPANASTASIOU, P. .; MEASE, P. J.; LEBWOHL, M. Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data. Acta Dermato-Venereologica, [S. l.], v. 102, p. adv00698, 2022. DOI: 10.2340/actadv.v102.563. Disponível em: https://medicaljournalssweden.se/actadv/article/view/563. Acesso em: 24 apr. 2024.